Clinical Trials Browser

Metastatic Adenocarcinoma of the Pancreas × Gastrointestinal × Clear all

NCT04083235 2026-03-09

NAPOLI 3

Phase 3 Completed

770 enrolled 13 charts 1 FDA

Gastrointestinal

Metastatic Adenocarcinoma of the Pancreas

NCT00873353 2010-08-18

XELTA

Phase 2 Completed

Gastrointestinal

Metastatic Adenocarcinoma of the Pancreas